Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
ViewRay Inc

Start price
Target price
Perf. (%)
€1.20
15.04.23
€1.00
15.04.24
-11.67%
29.04.23

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Dependend from some customers or products
high free float
nvestor 
15.04.23 50%
buy
Bovie Medical Corp

Start price
Target price
Perf. (%)
€5.90
28.05.22
-
28.05.23
-55.93%
24.04.23

Risky Investment
Lokrim 
28.05.22 20%
sell
Fluidigm Corp.

Start price
Target price
Perf. (%)
€1.68
27.06.22
-
27.06.23
-10.79%
24.04.23

Probably not worthwhile Investment
Lokrim 
27.06.22 20%
sell
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€2.81
19.09.22
-
19.09.23
-67.84%
24.04.23

Probably not worthwhile Investment
Lokrim 
19.09.22 20%
sell
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.42
15.05.22
-
15.05.23
81.90%
24.04.23

Risky Investment
Lokrim 
15.05.22 20%
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€4.16
10.10.22
-
10.10.23
94.71%
02.04.23

daimler1 
10.10.22 50%
buy
Evolent Health Inc

Start price
Target price
Perf. (%)
€28.40
29.03.22
-
29.03.23
-0.70%
29.03.23

Saftman 
29.03.22 50%
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€296.20
30.08.22
-
30.08.23
-37.71%
08.03.23

CrazyEights 
30.08.22 50%
buy
Nevro Corp.

Start price
Target price
Perf. (%)
€30.00
24.02.23
-
24.02.24
7.33%
04.03.23

platon 
24.02.23 0%
buy
Sientra Inc.

Start price
Target price
Perf. (%)
€1.84
02.02.23
€3.60
02.02.24
-4.62%
06.02.23

Could be very worthwhile Investment >20% year
DomRuinart 
02.02.23 50%
buy
Lantheus Holdings Inc

Start price
Target price
Perf. (%)
€69.50
03.11.22
-
03.11.23
-17.27%
05.02.23

Shooter 
03.11.22 50%
buy
Staar Surgical Co.

Start price
Target price
Perf. (%)
€73.22
16.10.22
-
16.10.23
-5.93%
05.02.23

Shooter 
16.10.22 50%
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€257.50
16.10.22
-
16.10.23
-31.86%
05.02.23

Shooter 
16.10.22 50%
buy
Lemaitre Vascular Inc

Start price
Target price
Perf. (%)
€48.80
16.10.22
-
16.10.23
-6.56%
05.02.23

Shooter 
16.10.22 50%
buy
Meridian Bioscience Inc.

Start price
Target price
Perf. (%)
€19.00
28.01.22
€20.00
28.01.23
62.63%
29.01.23

Could be worthwhile Investment >10% per year
melinda 
28.01.22 50%
buy
Varex Imaging Corp

Start price
Target price
Perf. (%)
€24.00
24.01.22
€28.00
24.01.23
-20.42%
25.01.23

Could be worthwhile Investment >10% per year
melinda 
24.01.22 50%
buy
Antares Pharma

Start price
Target price
Perf. (%)
€2.82
14.12.21
-
14.12.22
86.17%
15.12.22

melinda 
14.12.21 50%
buy
Orasure Tech

Start price
Target price
Perf. (%)
€7.64
14.12.21
-
14.12.22
-35.83%
15.12.22

melinda 
14.12.21 50%
buy
Fluidigm Corp.

Start price
Target price
Perf. (%)
€3.97
27.11.21
-
27.11.22
-64.56%
28.11.22

melinda 
27.11.21 0%
buy
Staar Surgical Co.

Start price
Target price
Perf. (%)
€76.94
30.03.22
€107.00
30.03.23
-23.50%
07.11.22

RudolfL 
30.03.22 60%
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€0.59
22.09.22
-
22.10.22
-57.95%
23.10.22

BLONDI 
22.09.22 50%
sell
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€0.000
10.10.23
-6.09%
16.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Ruckelsbuckel 
10.10.22 70%
sell
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€1.00
10.10.23
-6.09%
16.10.22

Marianka 
10.10.22 60%
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
BiotechBee 
29.09.22 50%
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
me8 
03.10.22 0%